DK0442423T3 - Anvendelse af buspiron ved søvnapnøer - Google Patents

Anvendelse af buspiron ved søvnapnøer

Info

Publication number
DK0442423T3
DK0442423T3 DK91101888.5T DK91101888T DK0442423T3 DK 0442423 T3 DK0442423 T3 DK 0442423T3 DK 91101888 T DK91101888 T DK 91101888T DK 0442423 T3 DK0442423 T3 DK 0442423T3
Authority
DK
Denmark
Prior art keywords
buspirone
sleep apnea
useful
treatment
pharmaceutically acceptable
Prior art date
Application number
DK91101888.5T
Other languages
Danish (da)
English (en)
Inventor
William C Dement
Mark R Rosekind
Jeffrey L Schwimmer
Original Assignee
Bristol Myers Squibb Co
Univ Stanford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Univ Stanford filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0442423T3 publication Critical patent/DK0442423T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK91101888.5T 1990-02-12 1991-02-11 Anvendelse af buspiron ved søvnapnøer DK0442423T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47980390A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
DK0442423T3 true DK0442423T3 (da) 1995-03-20

Family

ID=23905511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91101888.5T DK0442423T3 (da) 1990-02-12 1991-02-11 Anvendelse af buspiron ved søvnapnøer

Country Status (12)

Country Link
EP (1) EP0442423B1 (fr)
JP (1) JP3168543B2 (fr)
KR (1) KR910015300A (fr)
AT (1) ATE116854T1 (fr)
CA (1) CA2036055A1 (fr)
DE (1) DE69106543T2 (fr)
DK (1) DK0442423T3 (fr)
ES (1) ES2069758T3 (fr)
GR (1) GR3015716T3 (fr)
HK (1) HK1005016A1 (fr)
HU (1) HUT56496A (fr)
IL (1) IL97054A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
DK1066036T3 (da) * 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
CN101132777A (zh) 2004-12-20 2008-02-27 科利吉姆制药公司 用于睡眠障碍的药物组合物
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
JP2012526832A (ja) * 2009-05-13 2012-11-01 スノビオン プハルマセウトイカルス インコーポレイテッド トランスノルセルトラリン及びセロトニン受容体1a作動剤/拮抗剤を含む組成物及びその使用

Also Published As

Publication number Publication date
JP3168543B2 (ja) 2001-05-21
HU910436D0 (en) 1991-08-28
HUT56496A (en) 1991-09-30
IL97054A (en) 1995-10-31
IL97054A0 (en) 1992-03-29
CA2036055A1 (fr) 1991-08-13
EP0442423B1 (fr) 1995-01-11
DE69106543D1 (de) 1995-02-23
EP0442423A1 (fr) 1991-08-21
ES2069758T3 (es) 1995-05-16
JPH0826997A (ja) 1996-01-30
HK1005016A1 (en) 1998-12-18
KR910015300A (ko) 1991-09-30
GR3015716T3 (en) 1995-07-31
ATE116854T1 (de) 1995-01-15
DE69106543T2 (de) 1995-05-11

Similar Documents

Publication Publication Date Title
FI913142A0 (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
FI923677A7 (fi) Foerfarande och anordning foer entydig kombinering av foer en bestaemd behandling avsedda laekemedel med en bestaemd patient
FI902415A7 (fi) Oksadiatsolijohdannainen ja sen suolat, niiden käyttäminen dementian hoidossa, valmistus ja formulaatiot
FI875795A7 (fi) Valonsäteilyttämislaite käytettäväksi nenän- ja nielun tiehyeiden lääketieteelliseen hoitoon.
DE69125237D1 (de) Orthopädische Bandage
DK0768086T3 (da) Behandling af tinnitus med neurobeskyttende virksomme stoffer
FI931713A0 (fi) Med vattenhaltigt expansionsmedel framstaellt sulfonpolymerskum
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
FI932851L (fi) Foerfarande foer framstaellning av bentonitslam med en hoeg fastaemneshalt
FI902179A0 (fi) Elektrodmaettkropp foer anvaendning i vaetskeformiga omgivningar med hoeg temperatur och stark straolning.
DK0442423T3 (da) Anvendelse af buspiron ved søvnapnøer
FI911883L (fi) Ferroelektriskt vaetskekristallprov med hoeg kontrast och ljus.
DE69125803D1 (de) Melassehaltiges maltitolkristall und herstellung desselben
FI922877L (fi) Kristallina olefinpolymerer och sampolymerer i form av sfaeriska partiklar med hoeg porositet
FI932145A0 (fi) Nya b-karbolinderivat, deras framstaellning och anvaendning i laekemedel
FI971127A7 (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollagee nin kypsymis- ja rakentumishäiriöiden hoitamiseen
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
FI923458A7 (fi) 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
FI915676L (fi) Substituerade n-bensoyl-n'- (2-fenyletyl)-piperaziner.
FI911644A0 (fi) Terapeutisk foerening och komposition.
FI931034L (fi) Foerfarande foer framstaellning av propylenkarbonat med hoeg renhet och samtidig framstaellning av passiverade elektroder
DE59100375D1 (de) Abtastvorrichtung sowie Verwendung derselben.
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
DK435089D0 (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis